A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples